Actively Recruiting

Phase Not Applicable
Age: 40Years - 69Years
FEMALE
NCT07070778

Arterial Stiffness in Individuals With Breast Cancer

Led by Hacettepe University · Updated on 2025-12-29

18

Participants Needed

1

Research Sites

73 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of this study was to evaluate vascular toxicity induced by anthracyclines and other anticancer drugs and to measure arterial stiffness in women with breast cancer and, in addition, to evaluate the acute and chronic arterial stiffness responses of upper extremity aerobic exercise training.

CONDITIONS

Official Title

Arterial Stiffness in Individuals With Breast Cancer

Who Can Participate

Age: 40Years - 69Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Be between the ages of 40 and 69
  • Have a baseline left ventricular ejection fraction (LVEF) greater than 50%
  • Have no coronary artery disease or significant heart valve disease
  • Have no carotid atherosclerotic plaques
  • Be willing to participate in the study
  • Be at least 15 months after breast cancer surgery
  • Have no difficulty reading or understanding study scales and tests
  • Be physically inactive, doing less than 60 minutes of structured exercise per week
Not Eligible

You will not qualify if you...

  • Have an active infection
  • Have bilateral breast cancer
  • Have surgical, neurological, or orthopedic problems affecting upper limb function other than breast cancer surgery
  • Have neurological diseases or other diagnoses affecting cognitive status
  • Have left ventricular dysfunction or severe liver or kidney dysfunction before chemotherapy
  • Have musculoskeletal or neurological diseases affecting exercise performance, symptomatic heart disease, previous lung surgery, or malignant disease
  • Have unstable hypertension or diabetes mellitus

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hacettepe University

Ankara, State, Turkey (Türkiye), 06100

Actively Recruiting

Loading map...

Research Team

E

Ebru Calik Kutukcu, PhD

CONTACT

N

Naciye Vardar-Yagli, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here